Board of Directors

The CMPI Board of Directors is comprised of some of the nation’s leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future.

Gad Berdugo
General Partner,
Explorium Capital LLC

Fred Goodwin, M.D.
Professor of Psychiatry,
The George Washington University Medical Center.

Steven Sammut
Lecturer,
Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania

Michael Tew
Principal
SandHill RP

Mark Thornton, M.D., Ph.D.
Chairman and President,
Sarcoma Foundation of America

Michael Weber, M.D.
Professor of Medicine,
SUNY Downstate College of Medicine
Brooklyn, New York
Sign Up for Our Email Newsletter

RECENT NEWS

Peter Pitts on Fox News: How the pharmaceutical industry fits into the opioid crisis

Peter Pitts on Fox News: How the pharmaceutical industry fits into the opioid crisis

On 'Special Report,' Doug McKelway takes an in-depth look at the relationship between money and addiction...  Read more

How Trump and the FDA Can Create a Pharmaceutical Manufacturing Renaissance

How Trump and the FDA Can Create a Pharmaceutical Manufacturing Renaissance

In January, President Donald Trump said, “We have got to get our drug industry back.”...  Read more

ICER Devalues People With Rheumatoid Arthritis

ICER Devalues People With Rheumatoid Arthritis

ICER's 'studies' are the cold fusion experiments of health care economics. ...  Read more

DRUGWONKS BLOG